Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Prednisolone × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Follicular 4 Lymphoma 4 Burkitt Lymphoma 4 Ovarian Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Neoplasms 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hodgkin Disease 2 Endometrial Neoplasms 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Heart Failure 1 Esophageal Stenosis 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Cyclophosphamide 8 Biopsy 8 pembrolizumab 7 Specimen Handling 7 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Brentuximab Vedotin 6 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 fludarabine phosphate 4 duvelisib 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Etoposide 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡